Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
| Status: | Not yet recruiting |
|---|---|
| Healthy: | No |
| Age Range: | Any |
| Updated: | 8/12/2018 |
| Start Date: | June 2020 |
| End Date: | June 2022 |
| Contact: | Anup Katheria |
| Email: | anup.katheria@sharp.com |
| Phone: | 8589001219 |
An extension of the MINVI trial, the MINVI Follow-Up trial will evaluate the
neurodevelopmental outcomes at 22-26 months corrected age of term/near term infants who
received UCM or ECC.
neurodevelopmental outcomes at 22-26 months corrected age of term/near term infants who
received UCM or ECC.
The MINVI Follow-up trial will examine the difference in early childhood neurodevelopmental
impairment of subjects enrolled in the MINVI trial using standardized neurological and
developmental assessments at 22-26 months corrected age.
impairment of subjects enrolled in the MINVI trial using standardized neurological and
developmental assessments at 22-26 months corrected age.
Inclusion Criteria:
- Enrolled in MINVI trial who survive to 2 years corrected age
Exclusion Criteria:
- Enrolled in MINVI but did not survive to 2 years.
We found this trial at
7
sites
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials